Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study

16. april 2018 opdateret af: David Hsu, Stony Brook University
The present study would be the first to investigate the relationship between reward- and or social stimuli-induced dopamine (DA) release and neural function using a combined PET/fMRI approach. Data from this project conducted in healthy subjects will provide preliminary data for a larger grant application to study patient populations with known abnormalities in DA including schizophrenia, major depressive, substance use, and eating disorders.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Aim 1. To test the relationship between reward-induced dopamine (DA) release on changes in resting state functional connectivity (RSFC) in healthy subjects. In 20 healthy adults, the investigators will examine DA release (measured using positron emission tomography, PET) in the ventral striatum, thalamus, and prefrontal cortex, as previously described. Before and after the task the investigators will examine RSFC (measured using functional magnetic resonance imaging, fMRI) between these structures, which have been shown to form functional pathways serving motivation and emotion regulation in rodents and nonhuman primates. The investigators hypothesize that DA release will impact the functional relationship between these and other structures as determined by changes in RSFC.

Aim 2. To examine the relationship between dopamine release and the Reward Positivity (RewP) potential. Subjects will be presented with the option to participate in an event-related potential (ERP) study. The investigators will correlate the amount of DA release with the amplitude of the RewP potential, an ERP that is enhanced in reward versus non-reward circumstances. Based on previous studies, the investigators hypothesize that RewP amplitude will positively correlate with dopamine release in the nucleus accumbens.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

5

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • New York
      • Stony Brook, New York, Forenede Stater, 11794
        • Health Sciences Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 45 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

20 subjects (ages 18-45 years) will be included. Male and female representation will be about equal. No ethnic/racial/gender group is excluded.

Beskrivelse

Inclusion Criteria:

  1. Healthy men and women age 18-45 who have the capacity to consent to the protocol.
  2. Ability to understand and follow instructions and oriented to name, time, and place.
  3. A negative urine pregnancy and toxicology screen
  4. Willingness to abstain from using aspirin, NSAIDs, or anticoagulants during the study

Exclusion Criteria:

  1. Left-handed or ambidextrous
  2. History of seizures
  3. History of strokes
  4. Clinically significant, uncontrolled liver, kidney, cardiac, or pulmonary disease
  5. Terminal medical diagnosis consistent with survival < 1 year
  6. Serious mental impairment. Mini mental state exam of < 23/30
  7. Current or past DSM-IV Axis I or neurologic disorders
  8. Actively abusing substances, including alcohol (regular alcohol use during the past 6 months equal to or greater than 16 cans of beer per week or equivalent; use of street drugs or regular tobacco use during the past 6 months)
  9. Unstable medical condition (≥ 3 months), or serious medical illnesses during the past three months (e.g., serious infections)
  10. Unexplained loss of consciousness; history of traumatic brain injury involving loss of consciousness greater than 2 minutes
  11. Currently pregnant or breastfeeding, sexually active and of child-bearing potential and not using adequate contraceptive methods
  12. Childbirth or miscarriage during past 6 months, breastfeeding within 6 months of recruitment
  13. Allergic to latex and/or study pharmaceuticals
  14. Diabetes and/or unable to fast for up to 7 hours
  15. Unable to lie comfortably in the scanner for up to 4 consecutive hours
  16. Would receive a total of over 5 rems to a radiosensitive organ (bone marrow, gonads, lens of the eye) or 15 rems to any other organ or to the body as a whole during a 12 month period
  17. Contraindications for MRI including neurostimulators, implanted medical devices, metal in the body, claustrophobia, weight over 440 pounds, and girth size incompatible for scanner bore.
  18. Participation in a similar Social Feedback Task within 2 months of the start of the study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Dopamine receptor binding potential
Tidsramme: 1-3 weeks
changes in dopamine receptor binding potential will be measured during and after a reward task or social stimulus task
1-3 weeks
Resting state fMRI
Tidsramme: 1-3 weeks
Resting state functional connectivity will be measured using fMRI
1-3 weeks
Event-related potential (ERP) during reward
Tidsramme: 1-3 weeks
ERP during a reward task is measured
1-3 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juni 2016

Primær færdiggørelse (Faktiske)

1. december 2017

Studieafslutning (Faktiske)

1. december 2017

Datoer for studieregistrering

Først indsendt

13. juni 2016

Først indsendt, der opfyldte QC-kriterier

15. juni 2016

Først opslået (Skøn)

16. juni 2016

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. april 2018

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

16. april 2018

Sidst verificeret

1. april 2018

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • PET/MR Pilot

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner